BiotechTube
Visikol

Visikol

Whitehouse Station, United States· Est.
visikol.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Visikol is a U.S.-based contract research organization (CRO) founded in 2014, focusing on advanced in vitro models and imaging technologies to accelerate drug discovery. The company's core capabilities include sophisticated 3D cell culture assays, such as its proprietary Blood-Brain Barrier model and HUREL Micro Livers for DMPK studies, coupled with highly multiplexed tissue imaging services. It serves as an extension of its clients' R&D teams, with a customer base that includes all top 20 pharmaceutical companies and over 1,000 research labs, positioning it as a specialized partner in preclinical research.

Digital HealthAI / Machine Learning

Technology Platform

Advanced in vitro cell culture models (e.g., 3D BBB model, HUREL primary hepatocyte micro-livers) and highly multiplexed tissue imaging and analysis services.

Opportunities

Strong demand for more predictive, human-relevant preclinical models and high-content spatial biology data presents a significant growth opportunity.
Expansion into the vast small-to-mid-sized biotech sector and further integration of AI/ML for data analysis offer additional avenues for market penetration and service differentiation.

Risk Factors

Key risks include client concentration among large pharma, technological obsolescence if competitors develop superior models, and the operational challenge of scaling a high-quality, custom service business.
The company is also exposed to cyclical swings in biopharma R&D spending.

Competitive Landscape

Visikol competes in the preclinical CRO space against large, full-service CROs (e.g., Charles River, LabCorp) and smaller, niche players specializing in specific technologies like organ-on-a-chip or imaging. Its differentiation lies in the combination of sophisticated 3D cell culture models with high-plex imaging, acting as a deeply integrated, collaborative partner rather than a transactional service provider.

More companies in Diagnostics & Precision Medicine →More companies in United States →